MedPath

Prospective study to identify predictive sensitivity of neoadjuvant chemoradiotherapy for locally advanced rectal Cancer (Neoadjuvant-synchronus TS1+RT)

Not Applicable
Conditions
Rectal cancer (Ra, Rb, P) diagnosed as adenocarcinoma and preoperatively diagnosed T3/4 , N0-3.
Registration Number
JPRN-UMIN000003398
Lead Sponsor
Department of Surgery I, Oita University Faculty of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
35
Inclusion Criteria

Not provided

Exclusion Criteria

Cases that have crital drug sensitivity to TS-1 or multiple cacners, multiple colorectal cancers with activity.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath